Noveris Health Sciences Inc MYCOF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.80
- Day Range
- $0.73–0.73
- 52-Week Range
- $0.00–2.04
- Bid/Ask
- $1.15 / $2.00
- Shares Outstanding
- 58.55M
- Market Cap
- $42.74M
- Volume/Avg
- 10,036 / 7,074
Key Statistics
- Price/Earnings (Normalized)
- 0.40
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Noveris Health Sciences Inc is a biotech and life sciences company dedicated to developing and commercializing solutions for treating mental health problems and enhancing vitality. The company has a portfolio of patents it is seeking to commercialize, and is exploring opportunities in the stem cell industry. It is developing the next generation of medications and therapies to address mental health disorders such as nicotine addiction and post-traumatic stress disorder (PTSD).
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 3
- Website
- https://noveris.health
Valuation
|
Metric
|
MYCOF
|
|---|---|
Price/Earnings (Normalized) | 0.40 |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
MYCOF
Financial Strength
|
Metric
|
MYCOF
|
|---|---|
Quick Ratio | 0.26 |
Current Ratio | 0.31 |
Interest Coverage | — |
Quick Ratio
MYCOF
Profitability
|
Metric
|
MYCOF
|
|---|---|
Return on Assets (Normalized) | −300.95% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
MYCOF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|z#?M%y@$ | LOCK|H@QL | $67B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|>&Q$&th | LOCK|Dt<#? | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|>?<Y^B | LOCK|^<F | $41B | |||
| Zoetis Inc Class A
ZTS
| LOCK|x#hzrq% | LOCK|#q | $31B | |||
| Viatris Inc
VTRS
| LOCK|mQ&N%< | LOCK|$g? | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|SX> | LOCK|$Dz | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|wLh>!G | LOCK|&& | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|?$<<r<Y | LOCK|vN | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|Z?v@!Ym | LOCK|J#Ns | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|^Z!d&l | LOCK|>m | $2B |
United States